Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| AIDS Serodiagnosis | 1 | 2018 | 64 | 0.72 | Why? |
| Reproductive Health Services | 1 | 2020 | 222 | 0.66 | Why? |
| Sexually Transmitted Diseases | 2 | 2021 | 694 | 0.59 | Why? |
| Sexual Health | 1 | 2020 | 419 | 0.56 | Why? |
| New York City | 15 | 2021 | 7432 | 0.53 | Why? |
| Pre-Exposure Prophylaxis | 2 | 2018 | 1138 | 0.48 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.41 | Why? |
| Bipolar Disorder | 1 | 2017 | 744 | 0.37 | Why? |
| HIV Infections | 4 | 2021 | 11620 | 0.33 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.30 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.30 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.27 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.25 | Why? |
| African Americans | 1 | 2018 | 3363 | 0.25 | Why? |
| Intubation | 2 | 2020 | 437 | 0.22 | Why? |
| Rh-Hr Blood-Group System | 1 | 2020 | 55 | 0.21 | Why? |
| New York | 4 | 2021 | 2488 | 0.19 | Why? |
| Urban Population | 2 | 2019 | 2000 | 0.18 | Why? |
| Diarrhea | 2 | 2021 | 2743 | 0.18 | Why? |
| Chlamydia Infections | 1 | 2021 | 248 | 0.18 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.17 | Why? |
| Bacterial Infections | 2 | 2021 | 2229 | 0.17 | Why? |
| Gonorrhea | 1 | 2021 | 315 | 0.16 | Why? |
| Nausea | 1 | 2020 | 457 | 0.16 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.16 | Why? |
| Caribbean Region | 1 | 2017 | 349 | 0.15 | Why? |
| Organ Transplantation | 2 | 2021 | 2616 | 0.15 | Why? |
| Automation | 1 | 2018 | 429 | 0.15 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.15 | Why? |
| Vomiting | 1 | 2020 | 722 | 0.14 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.13 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.13 | Why? |
| Natural Language Processing | 1 | 2018 | 436 | 0.13 | Why? |
| Clostridium Infections | 1 | 2021 | 595 | 0.13 | Why? |
| Academic Medical Centers | 3 | 2020 | 3088 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.12 | Why? |
| Bacteremia | 2 | 2021 | 1372 | 0.12 | Why? |
| Coinfection | 3 | 2021 | 6820 | 0.12 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.11 | Why? |
| Long QT Syndrome | 1 | 2021 | 1047 | 0.11 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.11 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.10 | Why? |
| Hospitalization | 8 | 2021 | 54280 | 0.10 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.10 | Why? |
| Retrospective Studies | 14 | 2021 | 105322 | 0.10 | Why? |
| Hepacivirus | 1 | 2019 | 1509 | 0.10 | Why? |
| Male | 23 | 2021 | 367725 | 0.09 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2021 | 2328 | 0.09 | Why? |
| Mass Screening | 2 | 2018 | 8005 | 0.09 | Why? |
| Hepatitis C | 1 | 2019 | 1514 | 0.09 | Why? |
| Intubation, Intratracheal | 2 | 2020 | 3962 | 0.09 | Why? |
| Health Education | 1 | 2018 | 1539 | 0.08 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Female | 22 | 2021 | 380317 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.08 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Curriculum | 1 | 2018 | 3083 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.07 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.06 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.06 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.06 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.06 | Why? |
| Aged | 14 | 2021 | 215776 | 0.06 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.06 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 8811 | 0.05 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.05 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
| Adult | 13 | 2021 | 244371 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.05 | Why? |
| Sustained Virologic Response | 1 | 2020 | 378 | 0.05 | Why? |
| Directive Counseling | 1 | 2018 | 77 | 0.05 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.04 | Why? |
| Travel | 1 | 2017 | 7220 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.04 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Hospitals, Community | 1 | 2020 | 475 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.04 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 952 | 0.04 | Why? |
| School Health Services | 1 | 2018 | 294 | 0.03 | Why? |
| Linear Models | 1 | 2020 | 1914 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Furin | 1 | 2021 | 1054 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Radiography | 1 | 2020 | 1576 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Renal Replacement Therapy | 1 | 2020 | 1530 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.03 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.03 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2021 | 1766 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Health Personnel | 1 | 2018 | 29646 | 0.02 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.02 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Critical Illness | 2 | 2020 | 17281 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2021 | 5164 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
Zucker's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(298)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_